The most significant technical reference for "CP 63" is a clinical protocol established by the European Blood Alliance and managed by the .
: In biomedical engineering, CP-63 has been used as a specific patient designation in studies involving gyrocardiography (GCG) . Researchers use data from this specific case to demonstrate how heartbeat detection can be achieved without traditional ECG leads, focusing on the mechanical vibrations of the heart. The most significant technical reference for "CP 63"
: The protocol ensures that plasma donated by recovered patients—which contains high levels of neutralizing antibodies—is standardized, tracked, and distributed effectively to those in critical condition. The most significant technical reference for "CP 63"